Blood Pressures, High
Conditions
Interventions
This is a randomized, controlled, two-arm, double-blind clinical trial. After being selected according to the eligibility criteria, the volunteers will undergo an anamnesis to assess the presence of p
Sponsors
Escola de Nutrição
Universidade Federal de Ouro Preto
Eligibility
Age
19 Years to 60 Years
Inclusion criteria
Inclusion criteria: Individuals undergoing treatment for cardiovascular disease; aged 19 to 60 years; of both sexes; with systemic arterial hypertension; dyslipidemias; diabetes mellitus; and high cardiovascular risk, determined according to the parameters of the Brazilian Guideline for the Prevention of Cardiovascular Disease in Patients with Diabetes (2017)
Exclusion criteria
Exclusion criteria: Use of anti-inflammatory drugs, immunosuppressants, or benzodiazepines; pregnant or breastfeeding women; presence of a diagnosis of renal insufficiency; thyroid disease; smokers; individuals undergoing hormone therapy; patients using antioxidant dietary supplements; significant dietary changes in the last 4 months; patients who present any of these criteria after the start of the intervention; and individuals who report digital illiteracy will not be included in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Melatonin supplementation is capable of improving the inflammatory and sleep profile of people with cardiovascular diseases, contributing to their treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected. | — |
Countries
Brazil
Contacts
Public ContactAline Aguiar
Universidade Federal de Ouro Preto
Outcome results
None listed